Terray Therapeutics
Terray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology to explore molecules and their targets for the purpose of discovering and developing small molecule therapeutics.
2
Funding Rounds
$180.0m
Money raised
Overview
Terray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology to explore molecules and their targets for the purpose of discovering and developing small molecule therapeutics.
-
Website:
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Terray Therapeutics has raised a total of $180m in funding over 2 rounds.
Key Insights:
- Terray Therapeutics October 2024 Series B Funding Round: $120m
- Terray Series A round, February 2022: $60m
Terray Therapeutics October 2024 Series B Funding Round
$120m
Terray Series A round, February 2022
$60m
Industries
Terray Therapeutics is active in the following industries: